General Information of Drug (ID: DMG22F0)

Drug Name
AAV-hAADC gene therapy
Indication
Disease Entry ICD 11 Status REF
Parkinson disease 8A00.0 Phase 1 [1]
Cross-matching ID
TTD ID
D08IMP

References

1 ClinicalTrials.gov (NCT00229736) A Study of AAV-hAADC-2 in Subjects With Parkinson's Disease. U.S. National Institutes of Health.